Please login to the form below

Not currently logged in

HER2-positive non-small cell lung cancer

This page shows the latest HER2-positive non-small cell lung cancer news and features for those working in and with pharma, biotech and healthcare.

Roche's Kadcyla fails in gastric cancer trial

Roche's Kadcyla fails in gastric cancer trial

The trial is particularly disappointing as Kadcyla parent Herceptin has previously been shown to be effective in HER2-positive gastric cancer, and has been approved for this use for several years. ... expand its use into early breast cancer and is also

Latest news

  • Avastin approved for cervical cancer in EU Avastin approved for cervical cancer in EU

    Roche's Avastin has added to its long list of approved indications with a green light in the EU to treat cervical cancer. . ... It is also in trials for additional indications including adjuvant treatment of HER2-positive and HER2-negative breast cancer

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...